Pilot Study to Evaluate ActiMyo Measured Activity in Parkinson Disease Patients & Healthy Volunteers
Pre-QuantiPark is a pilot study to evaluate the reliability and responsiveness of ActiMyo measured activity in PD patients. The purpose of the study is to provide validation of the ActiMyo, an innovative home-recording device enabling use in clinical trials and as an innovative tool for PD patient care.
• Clinical diagnosis of idiopathic PD (UKPDSBB criteria)
• On stable parkinsonian medication regimen including levodopa for at least 4 weeks
• Male of female aged ≥18 years old
• Experiencing motor fluctuations and dyskinesia
• MoCA (Montreal Cognitive Assessment) ≥ 26
• Willing to adhere and comply to the protocol requirements as evi-dence by written informed consent
• Capable and willing to accurately using Actimyo
• Capable and willing to complete diaries
• Unlimited broadband internet access at home
• Agrees to be filmed
• Affiliated to or a beneficiary of a social security scheme
• PD patients subgroup #1 only: levodopa acute test scheduled as part of usual care
• Male of female matched by age with PD patients ; aged ≥ 18
• Willing to adhere and comply to the protocol requirements as evi-dence by written informed consent
• Capable and willing to accurately using Actimyo
• Capable and willing to complete diaries
• MoCA (Montreal Cognitive Assessment) ≥ 26
• Unlimited broadband internet access at home
• Agrees to be filmed
• Affiliated to or a beneficiary of a social security scheme